171 related articles for article (PubMed ID: 6153405)
1. Autologous humoral response to human gliomas and analysis of certain cell surface antigens: in vitro study with the use of microcytotoxicity and immune adherence assays.
Coakham HB; Kornblith PL; Quindlen EA; Pollock LA; Wood WC; Hartnett LC
J Natl Cancer Inst; 1980 Feb; 64(2):223-33. PubMed ID: 6153405
[TBL] [Abstract][Full Text] [Related]
2. Autologous serologic responses in glioma patients. Correlation with tumor grade and survival.
Kornblith PL; Coakham HB; Pollock LA; Wood WC; Green SB; Smith BH
Cancer; 1983 Dec; 52(12):2230-5. PubMed ID: 6640493
[TBL] [Abstract][Full Text] [Related]
3. Serologic analysis of nitrosourea-induced rat gliomas.
Pfreundschuh M; Cravioto H; Hochwald G; Ransohoff J
J Natl Cancer Inst; 1982 Mar; 68(3):501-5. PubMed ID: 6950179
[TBL] [Abstract][Full Text] [Related]
4. Two separate membrane-bound antigens on human glioma cells in tissue culture detected with sera from glioma patients by immunofluorescence.
Solheid C; Lauro G; Palladini G
J Neurol Sci; 1976 Nov; 30(1):55-64. PubMed ID: 789826
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms by which human gliomas may escape cellular immune attack.
Gately MK; Glaser M; McCarron RM; Dick SJ; Dick MD; Mettetal RW; Kornblith PL
Acta Neurochir (Wien); 1982; 64(3-4):175-97. PubMed ID: 6215833
[TBL] [Abstract][Full Text] [Related]
6. Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients.
Woosley RE; Mahaley MS; Mahaley JL; Miller GM; Brooks WH
J Neurosurg; 1977 Dec; 47(6):871-85. PubMed ID: 200722
[TBL] [Abstract][Full Text] [Related]
7. Serological analysis of tumor antigens in malignant glioma patients.
Yoshida S; Tanaka R; Ono K
Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the humoral response of glioma patients to a possible common tumor-associated antigen(s).
Martin-Achard A; Diserens AC; de Tribolet N; Carrel S
Int J Cancer; 1980 Feb; 25(2):219-24. PubMed ID: 7390650
[TBL] [Abstract][Full Text] [Related]
9. Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls.
Fischer U; Struss AK; Hemmer D; Pallasch CP; Steudel WI; Meese E
Clin Exp Immunol; 2001 Nov; 126(2):206-13. PubMed ID: 11703362
[TBL] [Abstract][Full Text] [Related]
10. Microcytotoxicity blocking assay for the detection and isolation of soluble astrocytoma association antigen.
Potter VP; Wood WC; Cohen AM; Kornblith PL
J Surg Oncol; 1984 Jul; 26(3):188-93. PubMed ID: 6547496
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic antibody responses in astrocytoma patients. An improved allogeneic assay.
Kornblith PL; Pollock LA; Coakham HB; Quindlen EA; Wood WC
J Neurosurg; 1979 Jul; 51(1):47-52. PubMed ID: 448418
[TBL] [Abstract][Full Text] [Related]
12. The humoral immune response of patients to their gliomas.
Coakham HB; Kornblith PL
Acta Neurochir Suppl (Wien); 1979; 28(2):475-9. PubMed ID: 290238
[No Abstract] [Full Text] [Related]
13. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas.
Schmits R; Cochlovius B; Treitz G; Regitz E; Ketter R; Preuss KD; Romeike BF; Pfreundschuh M
Int J Cancer; 2002 Mar; 98(1):73-7. PubMed ID: 11857388
[TBL] [Abstract][Full Text] [Related]
14. Complement fixation by IgM and IgG autoantibodies on cultured human glial cells.
Garson JA; Quindlen EA; Kornblith PL
J Neurosurg; 1981 Jul; 55(1):19-26. PubMed ID: 7017080
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas.
Gately MK; Glaser M; Dick SJ; Mettetal RW; Kornblith PL
J Natl Cancer Inst; 1982 Dec; 69(6):1245-54. PubMed ID: 6183477
[TBL] [Abstract][Full Text] [Related]
16. Natural antibodies to cell-surface antigens of human astrocytoma.
Pfreundschuh M; Röhrich M; Piotrowski W; Berlit P; Penzholz H
Int J Cancer; 1982 May; 29(5):517-21. PubMed ID: 7095897
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas.
Eggers AE
Neurology; 1972 Mar; 22(3):246-50. PubMed ID: 4334554
[No Abstract] [Full Text] [Related]
18. Specific cellular immune responses in patients with malignant gliomas.
Sheikh KM; Apuzzo ML; Weiss MH
Cancer Res; 1979 May; 39(5):1733-8. PubMed ID: 85487
[TBL] [Abstract][Full Text] [Related]
19. [Immunofluorescence microscopy of a malignant glioma with regard to the occurrence and significance of glioma specific antibodies].
Hackenberg P; Koschnike P
Psychiatr Neurol Med Psychol (Leipz); 1980 Apr; 32(4):206-13. PubMed ID: 7413856
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against human astrocytomas and their reactivity pattern.
Stavrou D; Keiditsch E; Schmidberger F; Bise K; Funke I; Eisenmenger W; Kurrle R; Martin B; Stocker U
J Neurol Sci; 1987 Sep; 80(2-3):205-20. PubMed ID: 3316507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
